We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pityriasis rosea infection in a COVID‐19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS‐CoV‐2 infection.
- Authors
Paolino, Giovanni; Di Nicola, Matteo Riccardo; Cantisani, Carmen; Mercuri, Santo Raffaele
- Abstract
Congruently, the cutaneous manifestation of PR, could be an initial or prodromal symptom of a SARS-CoV-2 infection8; accordingly, during the pandemic, a careful medical history needs to be taken in patients with PR lesions to rule out an underlying SARS-CoV-2 infection. Our evaluation shows how treatment of COVID-19-related PR, using a steroid therapy (associated with systemic antihistamine and topical moisturizing cream) may accelerate the PR healing process, at the same time, improving the clinical course associated with COVID-19. Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection.
- Subjects
COVID-19; SARS-CoV-2; PITYRIASIS rosea; TREATMENT effectiveness; PROGNOSIS; URTICARIA; COUGH
- Publication
Dermatologic Therapy, 2021, Vol 34, Issue 4, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.14972